Whether this enablement was intentional or accidental is unclear, but the page was quickly attacked by a former Taxotere patient, who flooded the screen with negative comments and accusations. Sanofi’s initial attempts to block this user seems to have fanned the flames, as she enlisted friends to post even more negative messages. Sanofi has since deleted all her posts, implemented a new terms of use, and established a moderated discussion board instead. Many lessons to keep in mind from this experience. You can read more details on the Pharma Marketing Blog here. Reference: The Krü Report: e-Patient Connections
Veröffentlicht am vob kwhctest
Posted in